Atropine 0.5% eyedrops for the treatment of children with low myopia

نویسندگان

  • Yan-rong Wang
  • Hong-Li Bian
  • Qi Wang
چکیده

BACKGROUND This study aimed to assess the efficacy and safety of atropine 0.5% eyedrops (ATE) for the treatment of children with low myopia (LM). METHODS In this study, a total of 126 children with LM were randomly divided into an intervention group (administered 0.5% ATE) and a control group (administered a placebo), with 63 children in each group. The outcome measurements were changes in the spherical equivalent (SE), and axial length (AL), as well as adverse events (AEs). RESULTS Compared with placebo, administration of 0.5% ATE led to less progression in LM, as measured by SE, and less increase in AL (P < .01). In addition, no serious AEs occurred in both the groups. CONCLUSION About 0.5% ATE was efficacious and safe for controlling myopia in children with LM.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops.

PURPOSE To compare the safety and efficacy of different concentrations of atropine eyedrops in controlling myopia progression over 5 years. DESIGN Randomized, double-masked clinical trial. PARTICIPANTS A total of 400 children originally randomized to receive atropine 0.5%, 0.1%, or 0.01% once daily in both eyes in a 2:2:1 ratio. METHODS Children received atropine for 24 months (phase 1), ...

متن کامل

Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).

PURPOSE Our previous study, Atropine for the Treatment of Myopia 1 (ATOM1), showed that atropine 1% eyedrops were effective in controlling myopic progression but with visual side effects resulting from cycloplegia and mydriasis. The aim of this study was to compare efficacy and visual side effects of 3 lower doses of atropine: 0.5%, 0.1%, and 0.01%. DESIGN Single-center, double-masked, random...

متن کامل

Interventions to retard myopia progression in children: an evidence-based update.

TOPIC To evaluate the efficacy of interventions such as eyedrops, bifocal lenses, or contact lenses in retarding the progression of myopia in myopic children. CLINICAL RELEVANCE Myopia is a common ocular disorder, and high myopia (myopia at least -6.0 diopters) is associated with potentially blinding conditions. At present, there are no general guidelines on interventions that may decrease my...

متن کامل

Sublingual administration of atropine eyedrops in children with excessive drooling – a pilot study

BACKGROUND Drooling can be a severe disability and have high impact on daily life. Reversible treatment is preferable. AIM To analyse whether sublingual administration of atropine eyedrops is a useful reversible treatment option for severe drooling in children with disabilities. DESIGN The study had a prospective, single-system research design. The participants served as their own controls....

متن کامل

An Important Step Forward in Myopia Prevention: Low-Dose Atropine.

The article by Chia et al (see www.aaojournal.org/article/ S0161-6420(15)00675-2/fulltext) in this issue of Ophthalmology reports 5-year follow-up from the Atropine for the Treatment of Myopia (ATOM) 2 study. ATOM2 now covers a 2-year initial phase using 0.5%, 0.1%, and 0.01% atropine, a 1-year washout period, and a further 2 years of treatment with 0.01% atropine in those who progressed more t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 96  شماره 

صفحات  -

تاریخ انتشار 2017